Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial

Becker, Jurgen C.; Gesierich, Anja H.; Leiter, Ulrike; Zimmer, Lisa; Hassel, Jessica C.; von Wasielewski, Imke; Ziemer, Mirjana; Fluck, Michael; Meier, Friedegund; Spillner, Alexandra N.; Schilling, Bastian; Eigentler, Thomas K.; Livingstone, Elisabeth; Ugurel, Selma; Angela, Yenny; Windemuth-Kieselbach, Christine; Gutzmer, Ralf; DeCOG

Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma: clinical activity and safety results from AliCe, a single-arm multicentre phase II DeCOG trial

Autor(en):

Becker, Jurgen C.; Gesierich, Anja H.; Leiter, Ulrike; Zimmer, Lisa; Hassel, Jessica C.; von Wasielewski, Imke; Ziemer, Mirjana; Fluck, Michael; Meier, Friedegund; Spillner, Alexandra N.; Schilling, Bastian; Eigentler, Thomas K.; Livingstone, Elisabeth; Ugurel, Selma; Angela, Yenny; Windemuth-Kieselbach, Christine; Gutzmer, Ralf; DeCOG

Tübinger Autor(en):

Leiter-Stöppke, Ulrike

Erschienen in:

British Journal of Dermatology (2025), Bd. 193, H. 5, S. 865-875

Verlagsangabe:

Oxford : Oxford Univ Press

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1093/bjd/ljaf303

ISSN:

0007-0963